Cipla Ltd. — Regulatory Filings 2021

Feb 8, 2021

8[th] February 2021

(1) BSE Ltd (2) National Stock Exchange of India Ltd Listing Department Listing Department Phiroze Jeejeebhoy Towers, Exchange Plaza, 5[th] floor, Dalal Street, Plot no. C/1, G Block, Mumbai - 400 001 Bandra Kurla Complex, Bandra (East), Mumbai - 400 051

Scrip Code: 500087 Scrip Code: CIPLA EQ

• (3) SOCIETE DE LA BOURSE DE LUXEMBOURG Societe Anonyme 35A Boulevard Joseph II, L-1840 Luxembourg

Sub: Intimation of Schedule of Analyst / Institutional Investor Meetings

Dear Sir/Madam,

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we herein mention the schedule of Analyst / Institutional Investor Meetings with the Company:

	Date	Fund / Investor Name	Venue	Type of Meeting
	09-February-2021	OrbiMed Healthcare Fund Management
	10-February-2021	Skerryvore Asset Management
	11-February-2021	Avendus Capital Public Markets Alternate Strategies LLP	-	Call
	12-February-2021	Edelweiss India e-Conference 2021 – India 2025: The New Order

The schedule of the abovementioned meetings is subject to change and the change may occur due to exigencies on the part of Investor / Company.

Thanking you,

Yours faithfully, For Cipla Limited RAJENDR Digitally signed by RAJENDRA CHOPRA DN: c=IN, o=Personal, 2.5.4.20=4987ad48c3965cfde78c8ea69e6 f40ac91535876f12ba1fa5ba45cc5cc8db6 A cb, postalCode=122001, st=HARYANA, serialNumber=0be85c0408d0e3afd6636 69f5314248a72fdcdf34d01d48d472d7cf9 262696f6, cn=RAJENDRA CHOPRA Date: 2021.02.08 14:05:26 +05'30' CHOPRA Rajendra Chopra Company Secretary

Prepared by: Juzer Masta